Blaze Bioscience

About:

Blaze Bioscience develops and commercializes products that assist surgeons to treat cancer patients.

Website: http://www.blazebioscience.com

Top Investors: Keiretsu Capital, Keiretsu Forum, W&W Capital, B Cubed Ventures

Description:

Blaze Bioscience is a Seattle-based, privately-held biotechnology company dedicated to developing products that assist surgeons in their quest to improve the lives of cancer patients. Tumor Paint provides real-time, high-resolution intraoperative visualization of cancer cells, enabling better detection and more complete and precise surgical resection of cancer. The first Tumor Paint product candidate, which is a combination of a targeting peptide and a fluorescent beacon, is under development for multiple solid tumors. Blaze Bioscience was founded in 2010.

Total Funding Amount:

$55.4M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2010-01-01

Contact Email:

info(AT)blazebioscience.com

Founders:

Heather Franklin, James Olson

Number of Employees:

11-50

Last Funding Date:

2019-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai